-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HiW7KcgOp6oxzxxkJQxbP8auXoKBFZI0j/3OgOG0clyc63uErg9ilANxkYJEI0aY 6Tavu+ODSbT4YchB14k/6A== 0001140361-07-012815.txt : 20070622 0001140361-07-012815.hdr.sgml : 20070622 20070622134232 ACCESSION NUMBER: 0001140361-07-012815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070620 FILED AS OF DATE: 20070622 DATE AS OF CHANGE: 20070622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAXE JON S CENTRAL INDEX KEY: 0001114914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 07936011 BUSINESS ADDRESS: BUSINESS PHONE: 7704429707 MAIL ADDRESS: STREET 1: FIRST HORIZON PHARMACEUTICAL CORP STREET 2: 660 HEMBREE PKWY STE 106 CITY: ROSWELL STATE: GA ZIP: 30076 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105741400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 doc1.xml FORM 4 X0202 4 2007-06-20 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001114914 SAXE JON S C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE FREMONT CA 94555 1 0 0 0 Stock Option (Right to buy) 23.89 2007-06-20 4 A 0 15000 0 A 2014-06-20 Common Stock 15000 15000 D Stock Option (Right to Buy) 23.89 2007-06-20 4 A 0 5000 0 A 2014-06-20 Common Stock 5000 5000 D Stock Option (Right to Buy) 23.89 2007-06-20 4 A 0 3000 0 A 2014-06-20 Common Stock 3000 3000 D Stock Option (Right to Buy) 23.89 2007-06-20 4 A 0 3000 0 A 2014-06-20 Common Stock 3000 3000 D This option will vest with respect to 1,250 shares on July 20, 2007 and with respect to 1,250 of the shares monthly thereafter. This option will vest with respect to approximately 417 shares on July 20, 2007 and with respect to approximately 417 of the shares monthly thereafter. This option will vest with respect to 250 shares on July 20, 2007 and with respect to 250 of the shares monthly thereafter. /s/ Francis Sarena by Francis Sarena, Attorney-in-Fact for Jon S. Saxe 2007-06-22 -----END PRIVACY-ENHANCED MESSAGE-----